Alpha interferon administration to infants with congenital rubella.
Three infants with congenital rubella syndrome were given human leukocyte (alpha) interferon at doses of 2 x 10(5) to 7 X 10(5) U/kg per day for 10 days. A transient decrease in pharyngeal virus excretion was observed with treatment. No significant side effects were associated with the administration of human leukocyte interferon to these infants.
D006801:Humans; D007124:Immunoenzyme Techniques; D007223:Infant; D007372:Interferons / Q000627:therapeutic use*; D010614:Pharynx / Q000382:microbiology; D012409:Rubella / Q000151:congenital* / Q000382:microbiology / Q000628:therapy; D012412:Rubella virus / Q000302:isolation & purification
D007372:Interferons